Stero Biotechs

CBD-based Treatment Solutions

Health Tech & Life Sciences
Active
Seed Bnei Brak, Israel Founded 2017
Last updated 2026-06-18
Total raised
$1.0M
Last: 2019-03
Stage
Seed
Founded
2017
Headcount
2
HQ
Bnei Brak, Israel
Sector
Health Tech & Life Sciences

About

STERO Biotechs is a clinical-stage company that researches and develops novel and improved treatment solutions designed to benefit patients by reducing the side effects of and need for steroid therapy. STERO uses cannabidiol (CBD), a non-psychotropic component of cannabis sativa, which has been shown to possess potent immunomodulatory and anti-inflammatory properties in a variety of indications. The company has commenced several clinical trials, including phase 2a clinical trials for steroid dependent Crohns disease (IBD) in Q1 2020 and for chronic urticaria (hives) in Q3 2020. In addition, STEROs phase 1/2 clinical trial treating patients with severe COVID-19 started in Q1 2021. Additional clinical trials for more indications are in the pipeline for 2021. STERO Biotechs was established in partnership with Mor Research Applications, the technology transfer unit of CLALIT Health Services.

Funding history · 1 round · $1.0M total

2019-03

Q&A

What is Stero Biotechs' primary focus?
Stero Biotechs is a clinical-stage company that researches and develops CBD-based treatment solutions to reduce the side effects and need for steroid therapy.
When was Stero Biotechs founded?
Stero Biotechs was founded in February 2017.
What is the employee count for Stero Biotechs?
Stero Biotechs has 1-10 employees.
What is Stero Biotechs' total funding to date?
Stero Biotechs has raised a total of $1,000,000 USD.
When did Stero Biotechs complete its last funding round?
Stero Biotechs completed its last funding round in March 2019.
What clinical trials has Stero Biotechs commenced?
Stero Biotechs commenced phase 2a clinical trials for steroid-dependent Crohn's disease in Q1 2020 and for chronic urticaria in Q3 2020. Additionally, a phase 1/2 clinical trial for severe COVID-19 patients started in Q1 2021.
Who is the CEO of Stero Biotechs?
David Bassa is the CEO and a founder of Stero Biotechs.
Is Stero Biotechs involved in any partnerships?
Stero Biotechs was established in partnership with Mor Research Applications, the technology transfer unit of CLALIT Health Services.

Team · 1

Founder · CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

autoimmune-diseasesanti-inflammatorybiotechnologydrug-deliverycannabismedical-cannabisinflammatory-diseasescrohn-s-diseaserespiratorytreatmentsdermatology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesterobiotechs.com
LinkedInlinkedin.com/company/15807532

Identifiers & details

Founded2017-2
Employees (exact)2

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domainsterobiotechs.com

Certificate / subdomain footprint

Subdomains8